- Home
- NRDY vs SERA Comparison
NRDY vs SERA Comparison
Compare NRDY & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- SERA
- Stock Information
- Founded
- NRDY 2007
- SERA 2008
- Country
- NRDY United States
- SERA United States
- Employees
- NRDY N/A
- SERA N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- SERA Precision Instruments
- Sector
- NRDY Technology
- SERA Health Care
- Exchange
- NRDY Nasdaq
- SERA Nasdaq
- Market Cap
- NRDY 220.5M
- SERA 208.7M
- IPO Year
- NRDY N/A
- SERA 2021
- Fundamental
- Price
- NRDY $1.98
- SERA $8.51
- Analyst Decision
- NRDY Hold
- SERA
- Analyst Count
- NRDY 8
- SERA 0
- Target Price
- NRDY $2.35
- SERA N/A
- AVG Volume (30 Days)
- NRDY 3.5M
- SERA 72.5K
- Earning Date
- NRDY 11-07-2024
- SERA 11-06-2024
- Dividend Yield
- NRDY N/A
- SERA N/A
- EPS Growth
- NRDY N/A
- SERA N/A
- EPS
- NRDY N/A
- SERA N/A
- Revenue
- NRDY $197,325,000.00
- SERA $94,000.00
- Revenue This Year
- NRDY N/A
- SERA N/A
- Revenue Next Year
- NRDY $2.86
- SERA $4,471.43
- P/E Ratio
- NRDY N/A
- SERA N/A
- Revenue Growth
- NRDY 9.55
- SERA N/A
- 52 Week Low
- NRDY $0.73
- SERA $4.90
- 52 Week High
- NRDY $3.60
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- NRDY 72.54
- SERA 62.57
- Support Level
- NRDY $1.46
- SERA $7.91
- Resistance Level
- NRDY $2.18
- SERA $8.95
- Average True Range (ATR)
- NRDY 0.25
- SERA 0.54
- MACD
- NRDY 0.02
- SERA 0.16
- Stochastic Oscillator
- NRDY 58.23
- SERA 80.99
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.